glp-1 pipeline news drug today 2025 Update: November Market Overview: GLP-1 Agonists and

VanderBeek noted that these findings echo a broader conversation about GLP-1 RA-associated eye complications

Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford Most Doubt the Trump Administration Will Lower Drug Costs for People Like Them, Though Three-Fourths of Republicans Expect It Will About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition, an increase from 18 months ago, though the high costs of the medications remain a concern, a new KFF Health Tracking Poll finds

[6] The good news is that this worst-case scenario is extremely rare, and with the right habits, constipation can usually be prevented or kept under control

J Neuroinflamm (2018) 15:337